Inactive Instrument

Analyst Reco. Daiichi Sankyo Company, Limited Other OTC

Equities

DSNKY

US23381D1028

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy	02-21	MT
Berenberg: AstraZeneca Set for More Lung Cancer Success After Recent Pipeline Gains	02-20	MT
Japan's Nikkei slips after Fed chair signals delay in rate cut	01-31	RE
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen	12-04	MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold	23-10-23	MT
Rising Interest Rates Lower Asian Stock Markets	23-10-19	MT
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen	23-09-25	MT
AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates	23-09-11	DJ
The Fed Opens Its Jackson Hole Conference With Interest Rate Path in Focus	23-08-24	DJ
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy	23-07-13	MT
AstraZeneca's Partner Daiichi Sankyo Says Enhertu Meets Objective Response Rate Target in Solid Tumors Phase 2 Trial	23-03-06	MT
Astrazeneca and Daiichi Sankyo's Enhertu Met Prespecified Criteria for Objective Response Rate and Duration of Response	23-03-06	CI
Japan's Nikkei ends at 1-month low amid political, rate-hike worries	23-02-22	RE
Nikkei drops to 1-month low on political tensions, rate-hike worries	23-02-21	RE
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy	22-12-14	MT
Nikkei little changed, pinned down by rates worry	22-11-20	RE
Japan's Nikkei snaps 5-day losing streak amid US rate caution	22-08-25	RE
MARKETSCREENER'S WORLD PRESS REVIEW : June 6, 2022	22-06-06
FTSE Flat, PMI Data Adds to Case for Another BoE Rate Increase	22-02-21	DJ
AstraZeneca-Daiichi Sankyo's Enhertu Improves Progression-Free Survival, Objective Response Rate in Brain Metastases Patients	21-12-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Daiichi Sankyo Company, Limited Other OTC

Equities

DSNKY

US23381D1028

Analyst Reco.

Filters